全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Significant Reduction of Vitamin B12 Levels in Sudanese Sickle Cell Disease Patients

DOI: 10.4236/oalib.1103208, PP. 1-7

Subject Areas: Hematology

Keywords: Vitamin B12, Cobalamin, Sickle Cell Disease, Sudan

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Vitamin B12 (Cobalamin) one of the most important vitamins for its normal functioning to maintain the nerve system and for their role in production of DNA. Objective: This study was aimed to measure and assess the serum Cobalamin levels in Sudanese patients with Sickle-cell disease (SCD) and compared with those without Sickle-cell disease. Materials and Method: This is a case control study conducted in Sudan during March 2015. A total of 160 volunteers were enrolled in this study. 80 were known Sudanese patients professionally diagnosed with homozygous sickle cell; their age ranged from 6 months to 15 years as patients group. Further 80 normal healthy were as control group; their age and gender were similar to patient group. Serum was prepared from clotted blood samples. The Cobalamin concentrations were measured in both groups of SCD patients and in a normal healthy control group using Enzyme Linked Immune immunosorbent assay method (ELISA), Map lap Plus-Italy. For statistical analysis, the laboratory parameters were compared between the two groups and tested for statistical significance using Statistical package for social scent (SPSS) version 20. Result: In this study the mean of serum Cobalamin in the sickle cell patients was statistically significantly lower compared with the normal non-sickle cell disease group with p value = 0.01. Conclusion: 7.1% of Sudanese sickle cell disease has a deficient serum Cobalamin (hypocobalaminemia).

Cite this paper

Ahmed, I. I. , Sir-Elfatouh, A. M. and Gaufri, N. E. A. M. (2016). Significant Reduction of Vitamin B12 Levels in Sudanese Sickle Cell Disease Patients. Open Access Library Journal, 3, e3208. doi: http://dx.doi.org/10.4236/oalib.1103208.

References

[1]  National Heart, Lungand Blood Institute (2016).
http://www.nhlbi.nih.gov/health/health-topics/topics/sca.
[2]  Rees, D.C., Williams, T.N. and Gladwin, M.T. (2010) Sickle Cell Disease. Lancet, 376, 2018- 2031.
https://doi.org/10.1016/S0140-6736(10)61029-X
[3]  Yamada, K. (2013) Chapter 9. Cobalt: It’s Role in Health and Disease. In: Sigel, A., Sigel, H. and Sigel, R.K.O., Eds., Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences 13, Springer, Berlin, 295-320.
https://doi.org/10.1007/978-94-007-7500-8_9
[4]  Herrmann, W. (2011) Vitamins in the Prevention of Human Diseases. Walter de Gruyter, Berlin, 245.
[5]  Hunt, A., Harrington, D. and Robinson, S. (2014) Vitamin B12 Deficiency. BMJ, 349, g5226. https://doi.org/10.1136/bmj.g5226
[6]  National Institutes of Health: Office of Dietary Supplements (2016) Dietary Supplement Fact Sheet: Vitamin B12—Health Professional Fact Sheet.
[7]  Lachner, C., Steinle, N.I. and Regenold, W.T. (2012) The Neuropsychiatry of Vitamin B12 Deficiency in Elderly Patients. The Journal of Neuropsychiatry and Clinical Neurosciences, 24, 5-15.
https://doi.org/10.1176/appi.neuropsych.11020052
[8]  McLean, E.D., Allen, L.H., Neumann, C.G., Peerson, J.M., Siekmann, J.H., Murphy, S.P., Bwibo, N.O. and Demment, M.W. (2007) Low Plasma Vitamin B-12 in Kenyan School Children Is Highly Prevalent and Improved by Supplemental Animal Source Foods. The Journal Nutrition, 137, 676-682.
[9]  Pfeiffer, C.M., Caudill, S.P., Gunter, E.W., Osterloh, J. and Sampson, E.J. (2005) Biochemical Indicators of B Vitamin Status in the US Population after Folic Acid Fortification: Results from the National Health and Nutrition Examination Survey 1999–2000. The American Journal of Clinical Nutrition, 82, 442-450.
[10]  Campbell, A.K., Miller, J.W., Green, R., Haan, M.N. and Allen, L.H. (2003) Plasma Vitamin B-12 Concentrations in an Elderly Latino Population Are Predicted by Serum Gastrin Concentrations and Crystalline Vitamin B-12 Intake. The Journal of Nutrition, 133, 2770- 2776.
[11]  Kittaka-Katsura, H., Fujita, T., Watanabe, F. and Nakano, Y. (2002) Purification and Characterization of a Corrinoid Compound from Chlorella Tablets as an Algal Health Food. Journal of Agricultural and Food Chemistry, 50, 4994-4997.
https://doi.org/10.1021/jf020345w
[12]  Watanabe, F., Takenaka, S., Kittaka-Katsura, H., Ebara, S. and Miyamoto, E. (2002) Characterization and Bioavailability of Vitamin B12-Compounds from Edible Algae. Journal of Nutritional Science and Vitaminology, 48, 325-231.
https://doi.org/10.3177/jnsv.48.325
[13]  Nakano, S., Takekoshi, H. and Nakano, M. (2010) Chlorella Pyrenoidosa Supplementation Reduces the Risk of Anemia, Proteinuria and Edema in Pregnant Women. Plant Foods for Human Nutrition, 65, 25-30.
https://doi.org/10.1007/s11130-009-0145-9
[14]  Lam, J.R., Schneider, J.L., Zhao, W. and Corley, D.A. (2013) Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency. JAMA, 310, 2435-2442.
https://doi.org/10.1001/jama.2013.280490
[15]  Yeomans, N.D., Hanson, R.G., Smallwood, R.A., Mihaly, G.W. and Louis, W.J. (1982) Effect of Chronic Ranitidine Treatment on Secretion of Intrinsic Factor. BMJ, 285, 264.
https://doi.org/10.1136/bmj.285.6337.264
[16]  Ting, R.Z., Szeto, C.C., Chan, M.H., Ma, K.K. and Chow, K.M. (2006) Risk Factors of Vitamin B(12) Deficiency in Patients Receiving Metformin. Archives of Internal Medicine, 166, 1975-1979.
https://doi.org/10.1001/archinte.166.18.1975
[17]  Kondo, H., Osborne, M.L., Kolhouse, J.F., Binder, M.J., Podell, E.R., Utley, C.S., Abrams, R.S. and Allen, R.H. (1981) Nitrous Oxide Has Multiple Deleterious Effects on Cobalamin Metabolism and Causes Decreases in Activities of Both Mammalian Cobalamin-Dependent Enzymes in Rats. The Journal of Clinical Investigation, 67, 1270-1283.
https://doi.org/10.1172/JCI110155
[18]  Schneede, J. and Ueland, P.M. (2005) Novel and Established Markers of Cobalamin Deficiency: Complementary or Exclusive Diagnostic Strategies. Seminars in Vascular Medicine, 5, 140-155.
https://doi.org/10.1055/s-2005-872399
[19]  Osifo, B.O., Adeyokunnu, A., Parmentier, Y., Gerard, P. and Nicolas, J.P. (1983) Abnormalities of Serum Transcobalamins in Sickle Cell Disease (HbSS) in Black Africa. Scandinavian Journal of Hematology, 30, 135-140.
https://doi.org/10.1111/j.1600-0609.1983.tb01459.x
[20]  Victorherbert.com. Argument for Providing B12 with Food Fortification of Folate, Since Otherwise Folate Will Correct Hematological Symptoms While Leaving Neurological Symptoms to Progress.
[21]  Al-Momen, A.K. (1995) Diminished Vitamin B12 Levels in Patients with Severe Sickle Cell Disease. Journal of Internal Medicine, 237, 551-555.
https://doi.org/10.1111/j.1365-2796.1995.tb00884.x
[22]  Segal, J.B., Miller, E.R., Brereton, N.H. and Resar, L.M. (2004) Concentrations of B Vitamins and Homocysteine in Children with Sickle Cell Anemia. Southern Medical Journal, 97, 149-155.
https://doi.org/10.1097/01.SMJ.0000051740.56511.93
[23]  Lowenthal, E.A., Mayo, M.S., Cornwell, P.E. and Thornley-Brown, D. (2000) Homocysteine Elevation in Sickle Cell Disease. Journal of the American College of Nutrition, 19, 608-612.
https://doi.org/10.1080/07315724.2000.10718958
[24]  van der Dijs, F.P., Schnog, J.J., Brouwer, D.A., Velvis, H.J., van den Berg, G.A., Bakker, A.J., Duits, A.J., Muskiet, F.D. and Muskiet, F.A. (1998) Elevated Homocysteine Levels Indicate Suboptimal Folate Status in Pediatric Sickle Cell Patients. American Journal of Hematology, 59, 192-198.
https://doi.org/10.1002/(SICI)1096-8652(199811)59:3<192::AID-AJH3>3.0.CO;2-8
[25]  Beutler, E., Lichtman, M.A., Coller, B.S., Kipps, T.J. and Williams, U. Hematology. 6th Edition, Churchill Livingstone, London, 469.
[26]  Mohammed, A.O., Attalla, B., Bashir, F., Ahmed, F.E., Elhassan GafarIbnauf, A., et al. (2006) Relation of Sickle Cell Gene to the Ethnic and Geographic Groups Populating the Sudan. Public Health Genomics, 9, 113-120.
https://doi.org/10.1159/000091489
[27]  Evatt, M.L., Mersereau, P.W., Bobo, J.K., Kimmons, J. and Williams, J. Why Vitamin B12 deficiency Should Be on Your Radar Screen. Centers for Disease Control and Prevention.
http://www.cdc.gov/ncbddd/b12/index.html
[28]  Lukanmbi, F.A. and Adeyokunnu, A. (1984) Serum Cobalamin Concentration in Sickle Cell Disease (HbSS). Acta Haematologica, 71, 299-303.
[29]  Kamineni, P., Chirla, S., Dinh, K., et al. (2006) Low Cobalamin Levels in African Americans with and without Sickle Cell Disease. Journal of the National Medical Association, 98, 352- 356.
[30]  Ajay, O.I., Bwayo-Weaver, S., Chirla, S., Serlemitsos-Day, M., Daniel, M., et al. (2013) Cobalamin Status in Sickle Cell Disease. International Journal of Laboratory Hematology, 35, 31-37.
https://doi.org/10.1111/j.1751-553X.2012.01457.x
[31]  Sinow, R.M., Johnson, C.S., Karnaze, D.S., Siegel, M.E. and Carmel, R. (1987) Unsuspected Pernicious Anemia in a Patient with Sickle Cell Disease Receiving Routine Folate Supplementation. Archives of Internal Medicine, 147, 1828-1829.
https://doi.org/10.1001/archinte.1987.00370100142023
[32]  Dhiman, R.K., Yusif, R.A., Nabar, U.J. and Albaqali, A. (2004) Gastrointestinal: Ischemic Enteritis and Sickle Cell Disease. Journal of Gastroenterology and Hepatology, 19, 1318.
https://doi.org/10.1111/j.1440-1746.2004.03630.x

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133